Intellipharmaceutics International Inc. Annual Operating Income (Loss) in CAD from 2014 to 2018

Taxonomy & unit
us-gaap: CAD and USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Intellipharmaceutics International Inc. annual/quarterly Operating Income (Loss) history and growth rate from 2014 to 2018.
  • Intellipharmaceutics International Inc. Operating Income (Loss) for the quarter ending May 31, 2017 was -CA$1.75M, a 8.13% increase year-over-year.
  • Intellipharmaceutics International Inc. annual Operating Income (Loss) for 2018 was -CA$13.3M, a 61.2% decline from 2017.
  • Intellipharmaceutics International Inc. annual Operating Income (Loss) for 2017 was -CA$8.27M, a 16.1% increase from 2016.
  • Intellipharmaceutics International Inc. annual Operating Income (Loss) for 2016 was -CA$9.85M, a 38.5% decline from 2015.
Operating Income (Loss), Annual (CAD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2018 -13.3M -5.06M -61.2% Dec 1, 2017 Nov 30, 2018 20-F/A 2019-03-04
2017 -8.27M +1.59M +16.1% Dec 1, 2016 Nov 30, 2017 20-F/A 2019-03-04
2016 -9.85M -2.74M -38.5% Dec 1, 2015 Nov 30, 2016 20-F/A 2019-03-04
2015 -7.11M -3.58M -101% Dec 1, 2014 Nov 30, 2015 20-F 2018-03-01
2014 -3.53M Dec 1, 2013 Nov 30, 2014 20-F 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.